Acasă › Cancer de sân › North Carolina › Durham
Studii clinice pentru Cancer de sân în Durham, NC
64 studii pentru Cancer de sân caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
În curs de recrutareFaza 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- University of North Carolina, Chapel Hill · La 10 mi distanță
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
În curs de recrutareFaza 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
În curs de recrutareStudiu observațional
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
În curs de recrutareFaza 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- University of North Carolina, Chapel Hill · La 10 mi distanță
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
În curs de recrutareFaza 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- University of North Carolina Medical Center, Chapel Hill · La 10 mi distanță
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
În curs de recrutareFaza 2
- University of North Carolina Medical Center, Chapel Hill · La 10 mi distanță
Identifying Patterns in the Breath of Individuals With Breast Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
În curs de recrutareFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
În curs de recrutareFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · La 10 mi distanță
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
În curs de recrutareStudiu observațional
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
În curs de recrutareFaza 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
În curs de recrutareFaza 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
În curs de recrutareFaza 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
În curs de recrutareFaza 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
- University of North Carolina-Hillsborough Campus, Hillsborough · La 13 mi distanță
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Optimizing Surgical Decisions in Young Adults With Breast Cancer
În curs de recrutare
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
În curs de recrutareStudiu observațional
- University of North Carolina, Chapel Hill · La 10 mi distanță
Weight Management After Cancer for Survivors in Rural Communities
În curs de recrutare
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
În curs de recrutare
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
În curs de recrutareFaza 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
În curs de recrutare
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
În curs de recrutareFaza 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
În curs de recrutare
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
În curs de recrutareFaza 1
- University of North Carolina, Chapel Hill · La 10 mi distanță
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
În curs de recrutare
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · La 10 mi distanță
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
În curs de recrutare
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
În curs de recrutareStudiu observațional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
În curs de recrutareFaza 1
- University of North Carolina, Chapel Hill · La 10 mi distanță
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- The University of North Carolina, Chapel Hill · La 10 mi distanță
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
În curs de recrutareStudiu observațional
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
În curs de recrutare
- University of North Carolina, Chapel Hill · La 10 mi distanță
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
În curs de recrutareFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · La 10 mi distanță
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
În curs de recrutareFaza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
În curs de recrutareFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
În curs de recrutare
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
În curs de recrutareFaza 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
În curs de recrutareStudiu observațional
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
În curs de recrutareFaza 2
- University of North Carolina, Chapel Hill · La 10 mi distanță
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
În curs de recrutareFaza 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
În curs de recrutare
- UNC Cancer Hospital, Chapel Hill · La 10 mi distanță
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
În curs de recrutare
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
În curs de recrutare
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
În curs de recrutare
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
BREAST Choice Decision Tool R21 - AIM2
În curs de recrutareVoluntari sănătoși bineveniți
- The University of North Carolina, Chapel Hill · La 10 mi distanță
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
În curs de recrutare
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Chapel Hill · La 10 mi distanță
UNC Pleural Fluid Registry
În curs de recrutareStudiu observațional
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
- Arlington, VA47 studii
Alte studii în Durham
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate39 studii
- Mielom multiplu37 studii
- Leucemie mieloasă acută33 studii
- Cancer metastatic33 studii
- Cancer de prostată32 studii
- Cancer pulmonar32 studii
- Cancer colorectal28 studii
- Cancer ovarian27 studii
- Leucemie limfatică cronică27 studii
- Insuficiență cardiacă26 studii
- Cancer pancreatic24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.